Stem Cell Research (Dec 2023)

Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene

  • C. Pavan,
  • J. Jin,
  • S. Jong,
  • D. Strbenac,
  • R.L. Davis,
  • C.M. Sue,
  • J. Johnston,
  • T. Lynch,
  • G. Halliday,
  • D. Kirik,
  • C.L. Parish,
  • L.H. Thompson,
  • D.A. Ovchinnikov

Journal volume & issue
Vol. 73
p. 103211

Abstract

Read online

The most common cause of autosomal recessive familial Parkinson’s disease (PD) are mutations in the PRKN/PARK2 gene encoding an E3 ubiquitin protein-ligase PARKIN. We report the generation of an iPSC cell line from the fibroblasts of a male PD patient carrying a common missense variant in exon 7 (p.Arg275Trp), and a 133 kb deletion encompassing exon 8, using transiently-present Sendai virus. The established line displays typical human primed iPSC morphology and expression of pluripotency-associated markers, normal karyotype without SNP array-detectable copy number variations and can give rise to derivatives of all three embryonic germ layers. We envisage the usefulness of this iPSC line, carrying a common and well-studied missense mutation in the RING1 domain of the PARKIN protein, for the elucidation of PARKIN-dependent mechanisms of PD using in vitro and in vivo models.